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that are the targets of several existing drugs9.
The complex life cycle of P. falciparum
means that the parasite has had to adapt to
several different environments. So it is also
intriguing that, compared with the genome of
the free-living budding yeast, the parasite
genome1 encodes a limited number of pre-
dicted transporter proteins for the active
uptake of nutrients from the environment. In
fact, entire classes of transporters seem to be
missing. It may be that several genes in this
class have been overlooked because they are
made up of many small coding regions, which
can be missed by gene-prediction algorithms.
But, taken at face value, this surprising finding
implies that adequate amounts of nutrients
recognized by the transporters must be 
present at all stages of the parasite life cycle, so
that there is no selective advantage in having
many transporters with differing substrate
specificities. Alternatively, the parasite may
use previously identified pores or channels 
to acquire nutrients10,11.
Regulating protein levels
During its life cycle, P. falciparum undergoes
several developmental changes. One of the
most dramatic is sexual differentiation and
the formation of gametes, male and female
reproductive cells. The proteomics studies3,7
of these stages have coincidentally shed light
on a fundamental question: how does the
parasite regulate the levels of its proteins?
The genome1 encodes relatively few predict-
ed proteins that control the transcription of
genes into messenger RNAs (the first step in
making a protein). Moreover, there seem to
be few transcriptional regulatory elements 
in the genome — or at least, there are few 
elements that are known from other organ-
isms. Yet the proteomics analyses and previ-
ous studies show that protein abundance is 
tightly regulated.
The proteomics studies also show that
proteins involved in processing mRNAs 
and in protein synthesis (translation) are
expressed at higher levels in gametocytes,
particularly female gametocytes, than in
other stages. Interestingly, proteins that are
present in early zygotes — which are pro-
duced from gametocytes — seem to be
absent in gametocytes, although the mRNAs
encoding these proteins are abundantly 
present. All of this is consistent with the 
proposal12 that the regulation of protein 
levels is controlled through mRNA process-
ing and translation, rather than by gene 
transcription. Perhaps this is a general 
feature of the parasite —  another potential
drug target.
In addition, one of the proteomics stud-
ies3 reveals groups of genes whose regulation
appears to be coordinated. Some simultane-
ously expressed genes are clustered in the
genome; comparison of these genes and their
flanking sequences may provide further
insight into how they are regulated.
Immune evasion
Arguably the most striking features of the P.
falciparum genome are the regions near the
ends of each chromosome1. This is where
families of genes that encode surface 
proteins, such as the var genes, are found.
These proteins, or antigens, can sometimes
be recognized by and thus stimulate the
human immune system. But they have a
great capacity for change, which occurs part-
ly through the exchange of material between
chromosome ends. As the genome sequence
shows, the very ends of the chromosomes —
the telomeres — have a complex arrange-
ment of sequences that may facilitate such
exchange (as described in ref. 13) and there-
by lead to immune evasion.
The general structure of the chromosome
ends is similar to that in the rodent parasite P.
yoelii yoelii2. But, surprisingly, the genes that
encode the variant surface antigens in P. falci-
parum are not found in P. yoelii yoelii, which
has a different family of variant genes, origi-
nally described in a less virulent human para-
site, P. vivax14. This is interesting, because it
suggests that P. yoelii yoelii, which is often
used as a model of P. falciparum, is in some
respects more similar to P. vivax. It is tempt-
ing to speculate that, despite their dissimilar
sequences, the genes at the ends of the P. falci-
parum and P. yoelii yoelii chromosomes have
similar functions. But that remains to be seen.
Finally, research on the P. falciparum var
genes has focused on their role in enabling
infected red blood cells to stick to small blood
vessels in the brain. This feature is associated
with the fatal form of the disease, cerebral
malaria. So it is interesting that one of the 
proteomics analyses3 reveals that the peptides
derived from many of the var genes occur in
sporozoites, which are produced in mosqui-
toes and invade the human liver during the
initial infection. These results point to possi-
ble alternative functions for vargene products.
The complete picture
One of the most exciting aspects of this huge
undertaking is that it can be related to other
work. We now have the genome of the 
mosquito A. gambiae15, together with draft
sequences of the human genome16,17, and so
can get a better handle on the interactions
among three species that have long been
evolving together. It is well known that cer-
tain variations in human genes are associat-
ed with a reduced susceptibility to malaria,
and analysis of different human populations
will no doubt reveal more on this. A close
look at the mosquito genome should pro-
vide similar insights. Study of the parasite
genome will reveal much about how P. falci-
parum interacts with its host and carrier, and
more about the genes involved in parasite
recognition by the human immune system.
Decoding the information in these genomes,
and translating it into effective remedies, is
both a challenge and an opportunity for the
scientific community. ■
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The papers that appear in this issue,describing the genome of the humanmalaria parasite Plasmodium falcipar-
um, are published simultaneously with others
in Science tackling the genome of the mosqui-
to Anopheles gambiae. The connection is 
obvious: the parasite requires a mosquito to
complete its complex life cycle and for trans-
mission from one host to another. These two
species are respectively the major parasite
causing malaria and the major vector.
Plasmodium is taken up by mosquitoes in
blood meals drawn from infected humans
(see the life-cycle diagram on page 495). The
parasite then undergoes several developmen-
tal stages, and crosses two mosquito cell layers
that enclose the insect’s midgut and salivary
glands. Ultimately, Plasmodium is passed on
when the mosquito bites a new human host,
about two weeks after ingesting the first
infected blood meal. For more than a century,
an objective of malaria control programmes
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The mosquito Anopheles gambiae is the main agent in the transmission of
human malaria. Its genome sequence will in time help to devise control
strategies, but will be a more immediate boon for insect biologists. 
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has been to block parasite transmission by
mosquitoes. These approaches will clearly
benefit from the improved understanding of
mosquito biology and mosquito interactions
with P. falciparum that the genome sequences
will make possible. 
The A. gambiae genome1 was sequenced
by a collaboration between Celera Genomics,
the French National Sequencing Centre
(Genoscope) and The Institute for Genomics
Research (TIGR), in association with several
university laboratories. These groups used
the same ‘shotgun’ strategy as that applied 
for sequencing the human, mouse and fruit-
fly (Drosophila melanogaster) genomes. 
Random fragments of genomic DNA were
first cloned in bacteria, and sequenced, and
the overlapping clones were then assembled
into contiguous sequences. Unexpectedly,
the high levels of genetic variation (polymor-
phisms) in the reference strain of A. gambiae
used for sequencing — the PEST strain —
made the genomic assembly step difficult.
The genetic variation might be explained by
the fact that two distinct populations of A.
gambiae have contributed to the PEST strain,
thereby creating a mosaic genome structure.
This unprecedented situation required the
development of new sequence-assembly
strategies, and these will be a considerable
asset for future genome projects — as with
mosquitoes, not all organisms are available as
inbred laboratory strains.
Comparison with the fruitfly
Much of the interest in the A. gambiae
genome will centre on comparisons with
that of D. melanogaster, which was published
two years ago2. These two insects belong 
to the same taxonomic order, the Diptera,
but inhabit distinct environments and 
have different lifestyles (Fig. 1). Drosophila
melanogaster feeds on decaying organic 
matter, such as damaged or rotting fruit,
where it also completes its life cycle, whereas
A. gambiae feeds on sugar nectar and on the
blood of vertebrate hosts. Blood meals are
required for female mosquitoes to produce
eggs; these are laid in water, where larvae
develop and hatch. Blood feeding exposes
the insect to viruses and parasites — like
Plasmodium, these other pathogens exploit
Anopheles as a vector for transmission. 
One of the main differences between the
two species is that, at 278 million base pairs,
the A. gambiae genome is much bigger than
that of D. melanogaster (estimated to be 180
million base pairs). But this difference is not
reflected in the total number of genes, which,
with 13,000–14,000 genes so far identified in
both insects, is surprisingly similar. It seems
that, in the course of evolution, Drosophila
has experienced a progressive reduction
both in the regions between genes and in the
introns, the non-protein-coding stretches of
DNA within genes. 
Comparison of the coding sequences
reveals that the genomes of Anopheles and
Drosophila are less similar than would be
expected for two species that diverged ‘only’
250 million years ago. Only half of the genes
in the two genomes can be interpreted as
orthologues — genes in different species that
have common ancestry, although their func-
tions may differ. Anopheles and Drosophila
orthologues show an average of about 56%
identity in DNA sequence. As Zdobnov 
et al. point out in another of the papers in 
Science 3, from the sequence standpoint, the
two species differ more than do humans and
pufferfish — species that diverged 450 mil-
lion years ago. Some of the protein families
present in both mosquito and fruitfly appear
to have evolved from a common ancestral
gene through independent gene-duplication
in each species. The Anopheles genome
shows several cases of such expansion which
might reflect adaptation to its lifestyle. An
example is the family of fibrinogen-like pro-
teins (of which there are 58 in Anopheles and
13 in Drosophila), which in the mosquito are
probably used as anticoagulant for the
ingested blood meals.
Defence mechanisms
Insects have efficient immune systems for
combating the various pathogens they
encounter, and most of our knowledge in
this area comes from genetic and molecular
studies in Drosophila. Finding out how
Anopheles responds to Plasmodium infection
is essential for obtaining clues to controlling
malaria. Christophides et al.4 analysed the
gene families in A. gambiae that are linked to
insect immunity, and show that they diverge
widely from those in Drosophila. Good
examples are the prophenoloxidase enzymes
(nine in the mosquito, three in the fruitfly);
these enzymes catalyse the synthesis of
melanin, which is associated with several
defence reactions in insects. 
The study by Christophides et al. suggests
that Anopheles employs the same general
defence mechanisms as Drosophila, and uses
similar pathogen-activated signal-transduc-
tion pathways, but that it has adapted recog-
nition and effector immune genes to different
types of aggressors. The best characterized
effector system in insects consists of antimic-
robial peptides, which display a wide spec-
trum of antibiotic activities. Interestingly,
out of seven families of these peptides found
in Drosophila, only two are also evident in
Anopheles: five, then, are specific to Drosoph-
ila. Conversely, at least one mosquito-specific
antimicrobial peptide has already been iden-
tified and others might be discovered by
functional studies in the future. The expres-
sion profiles of some A. gambiae immune
genes also suggest that, like the fruitfly, the
mosquito mounts specific immune respon-
ses adapted to different types of pathogen4,5. 
The availability of the entire DNA
sequence, together with tools such as DNA
microarrays and targeted gene disruption6–8,
will make Anopheles a powerful model sys-
tem for studying insect biology. The genom-
ic data will also help in developing strategies
to combat malaria and other mosquito-
borne human diseases, for example yellow
fever, dengue, filariasis and encephalitis.
Such strategies will include reducing the
number and lifespan of infectious mosqui-
toes, analysing what attracts them to their
human targets, and limiting the capacity of
parasites to develop within the insect vector.
Malaria is characterized by a highly complex
set of interactions between the parasite, the
vector and the host. Now that the genomes of
all three players have been fully sequenced,
the post-genomic era in combating this
dreadful disease can really begin. ■
Ennio De Gregorio and Bruno Lemaitre are at the
Centre de Génétique Moléculaire, CNRS, 
91198 Gif-sur-Yvette, France.
e-mails: gregorio@cgm.cnrs-gif.fr
lemaitre@cgm.cnrs-gif.fr  
1. Holt, R. A. et al. Science 298, 129–149 (2002).
2. Special section on the Drosophila genome Science 287,
2181–2224 (2000).
3. Zdobnov, A. M. et al. Science 298, 149–159 (2002).
4. Christophides, G. K. et al. Science 298, 159–165 (2002).
5. Dimopoulos, G. et al. Proc. Natl Acad. Sci. USA 99, 8814–8819
(2002).
6. Catteruccia, F. et al. Nature 405, 959 (2000).
7. Grossman, G. L. et al. Insect Mol. Biol. 10, 597–604 (2001).
8. Blandin, S. et al. EMBO Rep. 3, 852–856 (2002).
news and views
NATURE | VOL 419 | 3 OCTOBER 2002 | www.nature.com/nature 497
IN
ST
IT
U
T
 P
A
ST
E
U
R
/P
. B
R
E
Y
E
. D
E
 G
R
E
G
O
R
IO
Figure 1 The mosquito and the fruitfly in typical
pose — Anopheles (top) on human skin,
Drosophila on a banana. 
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